Donita Dyalram, MD, DDS

Dr. Dyalram is currently an assistant professor and associate program director in the Department of Oral and Maxillofacial Surgery at the University of Maryland Medical Center. She attended New York University College of Arts and Science for her undergraduate degree.  She then obtained her Dental Degree from New York University College of Dentistry and her Medical Degree from SUNY Downstate Medical Center.

At the completion of Oral Maxillofacial Surgical Residency training at SUNY Downstate Medical Center/ Kings County Hospital Center in NYC, she left her home town, to pursue fellowship training in Head and Neck Oncology and Microvascular Reconstruction at the University of Maryland Medical Center with Dr. Robert Ord and Dr. Joshua Lubek.  Here she received training and mentorship in surgical excellence that was second to none.  Following these two years of fellowship training, she accepted an academic positing at the University of Maryland Medical Center, Department of Oral Maxillofacial Surgery.

Since that time she has remained at the University of Maryland and she is presently the associate program director of the OMFS residency training program. The outstanding oral Maxillofacial Surgical Residency program at the University of Maryland trains 16 individuals.

She is one of the core faculty in the Head and Neck Oncology / Microvascular Reconstruction fellowship training program. Here she trains two fellows in ablative techniques and microvascular reconstruction.  She is also a course director and faculty advisor to students at the University of Maryland Dental School.

Dr. Dyalram had been awarded the prestigious Faculty Educator Development Award by the Oral Maxillofacial Surgery Foundation. This echoes her commitment as an educator to student, resident and fellows.

Dr. Dyalram is board-certified by the American Board of Oral & Maxillofacial Surgery. She is a member of the Face Transplant Team at the University of Maryland Medical Center.

Dr. Dyalram maintains a clinical interest in tumors of the jaw, benign and malignant; squamous cell carcinoma of the head and neck, salivary gland tumors, osteoradionecrosis and medication-related osteonecrosis of the jaw, head and neck reconstruction, robotic surgery and trigeminal nerve repair.